MAIA Biotechnology Files 8-K Report
Ticker: MAIA · Form: 8-K · Filed: Oct 27, 2025 · CIK: 1878313
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
MAIA Bio filed an 8-K on 10/27/25, mostly procedural stuff, no big news yet.
AI Summary
On October 27, 2025, MAIA Biotechnology, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no specific material events or financial details disclosed in the provided text. The report was filed in Delaware and its principal executive offices are located in Chicago, IL.
Why It Matters
This 8-K filing indicates MAIA Biotechnology, Inc. is providing updates or submitting required documentation to the SEC, though the specific nature of these events is not detailed in the excerpt.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report with no disclosed material events, financial changes, or executive actions that would immediately impact the company's risk profile.
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- October 27, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Chicago, IL (location) — Address of principal executive offices
- 001-41455 (identifier) — Commission File Number
FAQ
What is the primary purpose of this 8-K filing for MAIA Biotechnology, Inc.?
The filing is for "Other Events" and "Financial Statements and Exhibits" as of October 27, 2025.
When was this 8-K report filed by MAIA Biotechnology, Inc.?
The report was filed on October 27, 2025.
Where are the principal executive offices of MAIA Biotechnology, Inc. located?
The principal executive offices are located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.
In which state was MAIA Biotechnology, Inc. incorporated?
MAIA Biotechnology, Inc. was incorporated in Delaware.
What is the Commission File Number for MAIA Biotechnology, Inc.?
The Commission File Number is 001-41455.
Filing Stats: 801 words · 3 min read · ~3 pages · Grade level 14.4 · Accepted 2025-10-27 16:30:30
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 22KB
- 0001493152-25-019748.txt ( ) — 235KB
- maia-20251027.xsd (EX-101.SCH) — 3KB
- maia-20251027_lab.xml (EX-101.LAB) — 33KB
- maia-20251027_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 27 2025 MAIA BIOTECHNOLOGY, INC. By: /s/ Vlad Vitoc Name: Vlad Vitoc Title: Chief Executive Officer -3-